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ICP0 is a multi-functional herpes simplex virus type 1 (HSV-1) immediate-early (IE) gene product that contributes to efficient virus growth and
reactivation from latency. Here we show that HSV-1-induced cell-cycle arrest at the G2/M border requires ICP0 and Chk2 kinase and that ICP0
expression by transfection or infection induces ATM-dependent phosphorylation of Chk2 and Cdc25C. Infection of cells with a replication-defective
mutant virus deleted for all the regulatory IE genes except ICP0 (TOZ22R) induced G2/M arrest whereas a mutant virus deleted in addition for ICP0
(QOZ22R) failed to do so. Chk2-deficient cells and cells expressing a kinase-deficient Chk2 did not undergo cell-cycle arrest in response to TOZ22R
infection. Chk2 deficiency diminished the growth of wild-type HSV-1, but not the growth of an ICP0-deleted recombinant virus. Together, these results
are consistent with the interpretation that ICP0 activates a DNA damage response pathway to arrest cells in G2/M phase and promote virus growth.
© 2008 Elsevier Inc. All rights reserved.Keywords: HSV-1; Cell cycle; Chk2; DNA damage response; ICP0Introduction
Herpes simplex virus type 1 (HSV-1) is a neurotropic
human pathogen that establishes life-long latency in sensory
neurons (Steiner et al., 2007; Stevens, 1989). During latency,
the viral DNA exists in a quiescent episomal state wherein
expression is restricted to the latency-associated transcripts
(LATs) (Steiner et al., 2007). In response to a variety of
stress-associated stimuli, the virus is derepressed resulting in
resumption of viral gene expression and synthesis of new
virus. In the replicative stage, three classes of genes, referred
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doi:10.1016/j.virol.2008.01.038expressed in a tightly-regulated, well-ordered cascade (Honess
and Roizman, 1974; Roizman and Knipe, 2001). One of the
IE gene products, ICP0 (also known as Vmw110), is a multi-
functional protein that is essential for viral reactivation as
well as efficient virus growth following infection at low
multiplicity (Cai and Schaffer, 1989; Everett, 2000). Conse-
quently, HSV-1 mutants defective for ICP0 are severely
impaired for replication in normal fibroblast cultures and fail
to reactivate from latency in rodent models (Sacks and
Schaffer, 1987).
The activities of ICP0 are mainly linked to two properties, its
transactivation potential and its ability to degrade intracellular
proteins (Cai and Schaffer, 1989; Everett, 2000). ICP0 has been
reported to bind the Co-REST/REST/HDAC-1 repressor com-
plex and induce the dissociation of HDAC-1, thus promoting the
formation of euchromatin within the virus genome (Gu et al.,
2005; Zhang and Jones, 2001). Its protein destabilizing property is
linked to two functionally independent E3-ubiquitin (Ub) ligase
domains. ICP0 associates with nuclear domain 10 (ND10) struc-
tures (also known as PML bodies), causing the degradation of
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Roizman, 2003). ICP0 also triggers the degradation of p53, im-
parting resistance to UV-induced apoptosis in infected cells
(Boutell and Everett, 2004), and DNA-PKcs, the catalytic subunit
of DNA-dependent protein kinase (DNA-PK) (Lees-Miller et al.,
1996; Parkinson et al., 1999).
Recent investigations have suggested a role for ICP0 in
HSV-1-induced cell-cycle arrest at both the G1/S and G2/M
boundaries (Hobbs and DeLuca, 1999; Lomonte and Everett,
1999). ICP27 plays a key role in the establishment of G1/S
arrest while ICP0, along with other viral products, contributes to
the inhibition of G1-specific processes such as the induction and
maintenance of G1 cyclin kinase activities and consequent
hyperphosphorylation of the retinoblastoma protein (Ehmann
et al., 2000; Song et al., 2000, 2001). Unlike the G1/S block, the
mitotic block requires ICP0 as viruses that are deficient for this
protein prevent progression into S phase, but not through the
G2/M boundary (Lomonte and Everett, 1999). The mechanism
by which ICP0 affects the cell cycle is not known, but it has
been shown that ICP0-induced degradation of CENP-A and
CENP-C, centromeric protein components of the inner plate of
human kinetochores, correlates well with cell-cycle stalling
during mitosis in HSV-1-infected cells (Everett et al., 1999;
Lomonte et al., 2001).Fig. 1. Virus constructs. (A) Structure of the ICP0+ (TOZ22R) and ICP0− (QOZ22R) H
mutant virus TOZ.1. The HSV-1 genome is a linear, double-stranded DNA of ~152 kb
by inverted repeats (IRL, internal repeat of the long segment; IRS, internal repeat of the
the short segment). TOZ.1 contains a lacZ expression construct in the UL41 gene, has
portion of the ICP22 gene replaced with the HCMV IE promoter fused to the bovine gr
from TOZ.1 by substitution of the interrupted ICP22 coding sequence with the DsRed
ICP0 coding region with an eGFP expression construct. Black bars, gene deletions; co
identified by their numbers. (B) Southern blot demonstrating deletion of the ICP0 gene
with a probe for the ICP0 gene (top). Fragment sizes (in kbp) are indicated at the left of
the probe and relevant restriction sites indicated. Plain numbers refer to HSV-1 stra
preceded by a + sign indicate the distance in bp to the left boundary (SspI site) of the eG
Restriction sites that were lost in constructing the eGFP substitution of ICP0 in QOZ22
plasmid are shown in italics. The two copies of the ICP0 locus are identical in the reThe gene mutated in the human disorder ataxia-telangiectasia
(A-T) encodes a protein kinase, termed ATM, that shares
homology with PI-3 kinases (McKinnon, 2004). ATM plays a
critical role in double-stranded DNA break (DSB)-induced cellu-
lar responses, including those induced by ionizing radiation (IR)
(Kastan and Lim, 2000; McKinnon, 2004). Following DNA
damage, ATM is catalytically activated through dimerization and
auto-phosphorylation of S1981 (Bakkenist and Kastan, 2003).
Activated ATM, in turn, phosphorylates a number of downstream
targets including Brca1, Nbs1, p53, and the cell-cycle checkpoint
kinase Chk2 (Ahn et al., 2003; Bakkenist and Kastan, 2003;
Kastan and Lim, 2000; McKinnon, 2004). ATM activates the
kinase activity of Chk2 by phosphorylation of residue T68 (Mat-
suoka et al., 2000), although ATM-independent Chk2 phosphor-
ylation and activation have also been reported (Ahn et al., 2000;
Chen et al., 2002; Matsuoka et al., 1998; Wang et al., 2006). In a
parallel signaling pathway, the structurally and functionally rela-
ted kinase ATR stimulates Chk1 kinase through phosphorylation
on S345 and S317 in response to UV light-induced DNA damage
and agents that block replication (Liu et al., 2000; Zhao and
Piwnica-Worms, 2001). Both Chk1 and Chk2 kinases phosphor-
ylate the cell-cycle regulatory phosphatase Cdc25C on residue
S216 (Blasina et al., 1999; Matsuoka et al., 1998; Sanchez et al.,
1997), facilitating its binding to the molecular chaperone 14-3-3SV-1 strain KOSmutant viruses compared to wild-type HSV-1KOS and parental
characterized by unique long (UL) and unique short (US) segments, each flanked
short segment; TRL, terminal repeat of the long segment; TRS, terminal repeat of
complete deletions of the essential IE genes ICP4 and ICP27, and has an internal
owth hormone polyadenylation region (Krisky et al., 1998). TOZ22Rwas derived
2 gene. QOZ22Rwas derived from TOZ22R by replacement of both copies of the
lored bars, gene substitutions. Blue, lacZ; red, DsRed2; green, eGFP. IE genes are
in QOZ22R.Viral DNAswere digestedwithDraI andBamHI and the blot reacted
the autoradiograph. The target locus is illustrated underneath with the location of
in 17 map positions (GenBank accession no. X14112) while italicized numbers
FP insertion in QOZ22R. D, DraI; B, BamHI; H, HpaI; St, StuI; S, SspI; A, AseI.
R are shown between parentheses. Restriction sites derived from the eGFP donor
gion represented here.
Fig. 2. HSV-1 ICP0 activation of Chk2 kinase. (A) 293Tcells were infected at an
MOI of 2 with TOZ22R or QOZ22R and harvested at 0–24 h post-infection
(hpi). Cell lysates were electrophoresed and examined by immunoblotting with
the indicated general or phospho-specific antibodies. The lanes are labeled by
time point (hpi). (B) 293T cells were transfected with plasmid E110 expressing
ICP0 or with empty plasmid. Cells were harvested 24 h later and processed for
immunoblotting with the indicated antibodies.
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(Peng et al., 1997). In addition, inactivation of Cdc25C in res-
ponse to certain genotoxins by direct degradation in the ubiquitin-
proteosome pathway has been reported (Chen et al., 2002). Since
Cdc25C is required for activation of Cdk1/Cdc2 and cell entry
into mitosis, Cdc25C inactivation is widely viewed as a key event
in the establishment of the G2/M checkpoint (Peng et al., 1997;
Sanchez et al., 1997; Strausfeld et al., 1991).
In this report, we show that HSV-1 ICP0 expression is asso-
ciated with activation of Chk2 kinase through anATM-dependent
mechanism and that Chk2 is required for ICP0-induced G2/M
arrest. We found that Cdc25C was phosphorylated when Chk2
and ATM were activated by ICP0, suggesting that ICP0-induced
G2/M arrest takes effect through nuclear exclusion of Cdc25C.
Cellular Chk2 deficiency reduced the growth ofwild-typeHSV-1,
but did not further diminish the already impaired growth of an
ICP0-deficient mutant virus. Together, these results support a role
for ICP0 activation of the ATM-Chk2–Cdc25C signaling cascade
in both the establishment of HSV-1-induced G2/M arrest and
HSV-1 growth.
Results
HSV-1 ICP0 activates Chk2 kinase
HSV-1 infection is associated with inhibition of host cell
DNA synthesis and cell-cycle progression (Hobbs and DeLuca,
1999; Lomonte and Everett, 1999). Although the HSV-1 IE gene
product ICP0 has been implicated in halting cell-cycle pro-
gression, the precise mechanism by which ICP0 triggers this
response is not known. Given that the DNA damage checkpoint
kinases, Chk1 and Chk2, regulate cell-cycle arrest responses to
genotoxin-induced stress, we asked whether these kinases are
targeted for activation by HSV-1 ICP0. To test this possibility,
293T cells were infected with a replication-defective mutant
HSV-1 virus, TOZ22R, in which all of the IE genes are deleted
except ICP0 and ICP47 (Fig. 1), and Chk1 and Chk2 activations
were assessed by immunoblotting with phospho-specific anti-
Chk1 (S317) and anti-Chk2 (T68) antibodies. As a control virus,
we used mutant QOZ22R, a derivative of TOZ22R additionally
deleted for ICP0 (Fig. 1). As shown in Fig. 2A, infection of 293T
cells with TOZ22R at anMOI of 2 resulted in Chk2 activation, as
demonstrated by increased Chk2 T68 phosphorylation as early as
4 h post-infection. The control virus QOZ22R, however, failed to
activate Chk2. Moreover, neither TOZ22R nor QOZ22R acti-
vated Chk1 kinase. Anti-ICP0 immunoblotting confirmed the
expression of ICP0 in TOZ22R, but not in QOZ22R virus-
infected cells. Thus, ICP0 expression was specifically associated
with activation of Chk2, but not Chk1 kinase. Activation of Chk2
by ICP0 is not cell-type specific since similar results were ob-
tained with HCT116 cells (see below) and HeLa cells (data not
shown).
We next investigated whether ICP0 expression is sufficient for
Chk2 activation. To accomplish this, 293T cells were transfected
with an ICP0 expression plasmid and 24 h post-transfection cell
extracts were prepared and subjected to immunoblotting with
phospho-specific (T68) Chk2 antibody. Consistent with the re-sults obtained for TOZ22R-infected cells, lysates prepared from
ICP0 transfectants displayed robust Chk2 T68 phosphorylation
indicating activation, but no Chk1 S317 phosphorylation
(Fig. 2B). Anti-Chk1 and anti-Chk2 immunoblottings confirmed
that the steady-state levels of these proteins were not affected by
ICP0 expression. Since the control cells were transfected with
empty vector, Chk2 phosphorylation in the ICP0-transfected cells
was not due to the introduction of foreign DNA. Thus, ICP0 alone
is capable of activating the cell-cycle checkpoint kinase Chk2.
ICP0-induced G2/M arrest is Chk2-dependent and correlates
with Cdc25C S216 phosphorylation
As an element of DNA damage checkpoints, the Chk2 kinase
regulates cell-cycle arrest at the G2/M border through phos-
phorylation and inactivation of Cdc25C (Masrouha et al., 2003;
McKinnon, 2004). To determine whether the ICP0-dependent
G2/M arrest response to HSV infection requires Chk2, we
infected HCT116 and HCT116(Chk2−/−) cells with TOZ22R or
QOZ22R andmonitored cell-cycle inhibition by flow cytometry.
At 24 h post-infection, the population of HCT116 cells in G2/M
phase was increased in the TOZ22R-infected culture compared
to the mock-infected control (~39% vs. ~25%; Fig. 3A, left
Fig. 3. Chk2 kinase requirement for ICP0-induced G2/M arrest. (A) HCT116 and HCT116(Chk2−/−) cells were mock-infected or infected with TOZ22R or QOZ22R at
an MOI of 2. At 24 hpi, the cells were fixed, stained with propidium iodide and subjected to flow cytometric analysis. The numbers inside the panels show the
percentage of cells in G1, S, and G2/M phase. Since the total number of viable cells differs between the panels, absolute peak surfaces can not be compared between the
panels. (B) Chk2-deficient HCT15 cells and HCT15 cells complemented with either wild-type Chk2 [HCT15(Chk2+)] or kinase-deficient Chk2 [HCT15(Chk2-
T68A)] were mock-infected or infected with TOZ22R and cell-cycle progression analyzed at 24 hpi by flow cytometry. The percentage of cells in each phase is
indicated inside the panels. (C) HCT116 and HCT116(Chk2−/−) cells were mock-infected or infected with TOZ22R and harvested at 24 hpi for immunoblotting with
the indicated antibodies.
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ICP0-deleted QOZ22R virus did not inhibit cell-cycle progres-
sion. Notably, TOZ22R infection failed to induce the arrest
response in HCT116(Chk2−/−) cells as infected and uninfected
cultures displayed similar percentages of cells at the G2/M
border (mock, ~20%; TOZ22R, ~23%; Fig. 3A, right panels).
To examine whether the kinase function of Chk2 was neces-
sary for the Chk2-dependent G2/M block imposed by ICP0, wecompared HCT15 cells, a colorectal cancer cell line deficient in
Chk2 function, and HCT15 cells reconstituted with either wild-
type Chk2 or a kinase-defective mutant, Chk2-T68A (Wu and
Chen, 2003). Similar to our observations with HCT116 versus
HCT116(Chk2−/−) cells, TOZ22R infection of HCT15 cells ex-
pressing wild-type Chk2 resulted in G2/M arrest (~39% G2/M
compared to ~29% inmock-infected cells), while no increase was
observed in the G2/M population of the Chk2-deficient parental
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HCT15 cells expressing the kinase-inactive Chk2-T68A mutant
showed little accumulation of cells at theG2/Mborder in response
to TOZ22R infection (~26% G2/M, Fig. 3B), demonstrating that
the kinase function of Chk2 is indispensable for ICP0-induced
G2/M arrest.
To further support the conclusion from these results that ICP0-
induced G2/M arrest occurs through Chk2 activation, we deter-
mined whether Cdc25C was altered in TOZ22R-infected cells.
Phosphorylation of Cdc25C on residue S216 promotes binding
of the molecule to 14-3-3 proteins, which results in cytoplasmic
sequestration of Cdc25C and consequent failure to activate
nuclear Cdk1/Cdc2, a key player in cell-cycle progression to
mitosis (Graves et al., 2001). Compared to uninfected HCT116
cells, we observed a major increase in the amount of S216-
phosphorylated Cdc25C in TOZ22R-infected cells (Fig. 3C). In
contrast, Cdc25C phosphorylation on S216 was almost undetect-Fig. 4. ATM requirement for ICP0-induced Chk2 activation. (A, C) HCT116 cells and
infected with TOZ22R at an MOI of 2. At 24 hpi, cells were collected and lysates
indicated. (B) 293T cells were transfected with ICP0 expression plasmid E110 or e
untreated (Control) or treated with ionizing radiation (IR; 5 Gy, 137Cs source). Lysate
incubated for 1 h with or without 10 µM KU-55933 and transfected with plasmid E11
with fresh medium with or without the drug. Lysates were prepared 24 h later and aable in TOZ22R-infected HCT116(Chk2−/−) cells. The total
amount of Cdc25C was constant throughout and no signifi-
cant decrease was apparent in the level of Cdc25A, a regulator of
G1–S transition and S phase progression whose abundance is
controlled mainly by Chk1 (Xiao et al., 2003). Thus, the depen-
dence of G2/M arrest on ICP0 and Chk2 correlated with ICP0-
dependent Chk2 phosphorylation and Chk2-dependent inactiva-
tion of Cdc25C in cells infected with ICP0+ virus.
ATM is required for ICP0-dependent Chk2 activation
As an upstream effector kinase, ATM stimulates the kinase
activity of Chk2 by phosphorylating Chk2 on T68 following
DNA damage (Ahn et al., 2000). To determine if Chk2 activation
by ICP0 is dependent on ATM function, we infected HCT116
cells and three different ATM-deficient cell lines with TOZ22R
and examined Chk2 phosphorylation 24 h later. InfectedA-T fibroblast lines GM05849, GM02052 and GM09607 were mock-infected or
analyzed by immunoblotting with general and phospho-specific antibodies, as
GFP-expressing control plasmid pEGFP-C1. As additional controls, cells were
s were prepared 24 h later and analyzed by immunoblotting. (D) 293T cells were
0 in the presence or absence of the drug. The cells were washed and replenished
nalyzed by immunoblotting with the indicated antibodies.
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phosphorylation of ATM (Fig. 4A). In contrast, no virus-depen-
dent Chk2 activation was observed in the A-T lines, in agree-
ment with previous reports using wild-type HSV-1 (Lilley et al.,2005) or HSV-2 (Shirata et al., 2005). To determine whether
these results signified ATM activation by ICP0, we examined the
phosphorylation status of ATM in ICP0-transfected 293T cells.
The results showed increased S1981 phosphorylation of ATM in
19H. Li et al. / Virology 375 (2008) 13–23ICP0-transfected cells compared to mock-transfected cells
(Fig. 4B); γ-irradiated and untreated cells included as positive
and negative controls showed the expected activation of ATMby
IR. ICP0-transfected and IR-treated cells also displayed increa-
sed levels of S139-phosphorylated histone H2AX (γ-H2AX),
in addition to increased Chk2 phosphorylation as observed
earlier. In further experiments, we found that the Chk2-depen-
dent Cdc25C phosphorylation observed earlier in TOZ22R-
infected cells (Fig. 3C) requires ATM (Fig. 4C), and that the
ATM-specific inhibitor KU-55933 (Hickson et al., 2004)
blocked the ICP0-induced phosphorylation of ATM, Chk2 and
Cdc25C (Fig. 4D). Together, these results demonstrated that
ICP0 initiates ATM-dependent signaling to cell-cycle control
proteins similar to the damage response pathway activated by IR.
ICP0 promotes virus replication through Chk2 activation
The results to this point demonstrated that ICP0 and Chk2
are required for G2/M arrest in the absence of viral replication
and that these requirements correlate with the induction of a
DNA repair signaling cascade previously identified as a com-
ponent of the cellular response to HSV infection (Lilley et al.,
2005; Shirata et al., 2005). To relate these observations to the
lytic cycle of the virus, we compared the growth of wild-type
HSV-1 KOS and an ICP0-deficient, replication-competent mu-
tant virus, ICP0:lacZ, on HCT116 and HCT116(Chk2−/−) cells
infected at an MOI of 0.2. Virus yields were determined by
plaque assay on Vero or ICP0-complementing 7B0-104 cells.
ICP0:lacZ infection of HCT116 cells yielded approximately
100-fold less virus at 48 and 60 hpi than infection of the same
cells with wild-type virus, confirming that ICP0 contributes to
optimal virus growth at low MOI (Fig. 5A, B). Host-cell Chk2
deficiency reduced the growth rate and yields of the wild-type
virus (Fig. 5A) to an extent similar to that observed when ICP0
was deleted from the virus (Fig. 5B). In contrast, Chk2 defi-
ciency in the host cells did not further impair the growth of the
ICP0-deficient virus (Fig. 5B). These results demonstrated that
the growth-promoting effect of ICP0 requires the presence of
Chk2.
To determine whether activation of Chk2 correlated with
virus growth, two experiments were performed. In the first, we
asked whether virus production was affected by specific inhi-
bition of ATM. AD-293 cells, an adherence-improved cell line
derived from HEK293, were infected with HSV-1 KOS at an
MOI of 0.2 in the presence of increasing concentrations of KU-
55933, and virus yields were determined by plaque assay on
Vero cells at 18 hpi. As shown in Fig. 5C, yields decreased with
increasing drug concentrations. By cell viability assay onFig. 5. Chk2 requirement for efficient virus growth. (A, B) HCT116 and HCT116(C
(A) or ICP0-deficient mutant virus ICP0:lacZ (B). Cells plus media were harvested a
cells (A) or 7B0-104 cells (B). All infections were carried out at least in duplicate.
symbols and thus are not visible here. (C) AD-293 cells were incubated for 1 h with 0–
in the continued presence or absence of the drug. Cells were washed and fed with fres
determination of virus yields by plaque assay on Vero cells. (D) Mock-infected AD-2
MTS assay at 18 hpi for 10 wells per drug concentration. (E) 293T cells were infected
times indicated in hpi above the lanes. Immunoblotting was performed with the antib
MOI of 2 and processed 24 h later for flow cytometry.uninfected cultures treated in the same manner, we found that
these decreases could not be explained by cytotoxicity of the
drug (Fig. 5D). Thus these results were consistent with the
suggestion that the growth-promoting effect of Chk2 on wild-
type virus is dependent on ATM activity and thus likely invol-
ves the activated form of Chk2. In the second experiment, Chk2
phosphorylation was examined in 293T cells infected with
ICP0:lacZ or HSV-1 KOS. Although we used a 25-fold higher
MOI for ICP0:lacZ here (MOI=5) than in the growth expe-
riment with this virus (Fig. 5B), Chk2 T68 phosphorylation was
nearly undetectable (Fig. 5E). In contrast, phospho-T68 Chk2
was readily observed following wild-type virus infection perfor-
med at a 10-fold lower MOI (MOI=0.5). Likewise, phosphor-
ylation of the ATM substrate Brca1 on residue S1423, which is
required for IR-induced G2/M arrest (Xu et al., 2001), was
substantially less pronounced in ICP0:lacZ-infected cells than
in wild-type virus-infected cells. Viral ICP0 deficiency had a
smaller effect on γ-H2AX induction, which may be attributable
to compensatory activation of DNA-PK (Falck et al., 2005; Stiff
et al., 2004). Infection and replication were confirmed by exa-
mination of viral VP16 levels. VP16 is carried into the cells with
the infecting virus particles while de novo VP16 synthesis
requires viral DNA replication. Thus the early (4 hpi) detection
of VP16 in ICP0:lacZ-infected cells, but not KOS-infected
cells, is consistent with the MOI difference between the two
viruses, while the higher levels of VP16 at 8 and 16 hpi in KOS-
infected cells are indicative of more vigorous replication by the
wild-type virus. Cell-cycle analysis of ICP0:lacZ-infected cells
showed no evidence of G2/M arrest at 24 hpi (mock, 23% G2/
M; infected, 25% G2/M; Fig. 5F), in agreement with the lack of
significant Chk2 and Brca1 phosphorylation detected under
similar conditions. Together, these results supported the con-
clusion that ICP0 induces G2/M arrest through activation of
Chk2 and that these events are linked to the role of ICP0 in
promoting virus growth.
Discussion
Cell-cycle arrest in response to DNA damage is one aspect of
the cell's mechanism to preserve the integrity of its genome.
Temporary stalling of the cell cycle is thought to facilitate the
repair of lesions prior to cell division, thereby preventing the
propagation of mutations into daughter cells. Among the gro-
wing number of proteins recognized for their involvement in the
response to DNA damage, ATM plays a central role in the
induction of G2/M arrest following exposure of cells to ionizing
radiation. IR-induced ATM activation typically leads to phos-
phorylation and activation of the kinase function of Chk2,hk2−/−) cells were infected at an MOI of 0.2 with either wild-type HSV-1 KOS
t various times post-infection and viral yields assessed by plaque assays on Vero
Error bars in B and for certain data points in A are smaller than the data-point
30 µMKU-55933 and infected in duplicate with HSV-1 KOS (MOI=0.2) for 4 h
h medium with or without the drug. Cells and media were harvested at 18 hpi for
93 cells were incubated with KU-55933 as in (C) and cell viability measured by
with either HSV-1 KOS (MOI=0.5) or ICP0:lacZ (MOI=5) and harvested at the
odies shown. (F) 293T cells were mock-infected or infected with ICP0:lacZ at an
20 H. Li et al. / Virology 375 (2008) 13–23among other targets, which in turn results in phosphorylation of
various substrates, including Cdc25C at residue 216 [for recent
reviews, see Lavin and Kozlov (2007) and Shiloh (2006)].
Unlike other phosphorylated forms of Cdc25C, the S216-phos-
phorylated version is excluded from the nucleus where the
protein is required for G2/M progression. Consequently, cell-
cycle arrest takes effect.
HSV-1 infection, like infection by certain other viruses,
activates a cellular mechanism similar to the IR-induced DNA
damage response (Lilley et al., 2005; Shirata et al., 2005). It is
well established that damage to the host cell DNA promotes
virus reactivation from latency in HSV-1-infected sensory neu-
rons (Fogel et al., 1979). More recently, it has been demon-
strated that virus growth is impaired in mutant cells that lack key
components of the DNA damage response machinery (Lilley
et al., 2005). Such observations support the suggestion that
HSV-1 exploits cellular response mechanisms to DNA damage
for its own optimal growth (Lilley et al., 2007). Recent studies
have mapped significant portions of the HSV-1-induced damage
response pathway, showing early activation of ATM followed
by modification of downstream targets such as Chk2 and Nbs1
(Lilley et al., 2005; Shirata et al., 2005), the latter a component
of the MRN (Mre11) complex which accumulates at sites of
viral DNA replication and normally functions in cellular DNA
repair (Assenmacher and Hopfner, 2004; Lee and Paull, 2005;
Lilley et al., 2005; Taylor and Knipe, 2004; Wilkinson and
Weller, 2004). While the precise trigger of this HSV-1-respon-
sive pathway remains unknown, candidates include cellular re-
cognition of stalled viral replication forks or pre-replicative viral
genome structures as damaged DNA, or recombination during
virus replication (Lilley et al., 2005; Taylor and Knipe, 2004;
Wilkinson and Weller, 2004; Wilkinson and Weller, 2005).
Much like cellular DNA damage, HSV-1 infection results in
interruption of cell-cycle progression (Ehmann et al., 2000;
Song et al., 2001). Hobbs and DeLuca previously reported that
expression of ICP0 from a viral genome that is defective for
expression of all other viral IE proteins results in p53-indepen-
dent cell-cycle arrest in G1/S and G2/M whereas an isogenic
variant that expressed none of the IE genes showed no effect on
the cell cycle (Hobbs and DeLuca, 1999). Likewise, Lomonte
and Everett have shown that ICP0 plays a key role in HSV-1-
mediated inhibition of cell-cycle progression through the G1/S
boundary as well as mitosis (Lomonte and Everett, 1999).
Lilley et al. have shown that HSV-1 growth is impaired by
deficiencies in the virus-induced DNA damage response, such as
ATM deficiency or the absence of functional Mre11 protein
(Lilley et al., 2005). While these results are at odds with the
reported observation that shRNA-mediated ATM knock-down
in 293Tcells does not affect HSV-2 growth (Shirata et al., 2005),
they are consistent with our findings that wild-type HSV-1 yields
are reduced on Chk2-deficient cells and in the presence of the
ATM-specific inhibitor KU-55933; we have not explored the
apparent discrepancy with the HSV-2 results. It is also well
established that ICP0-deficient HSV-1 growth is impaired at low
multiplicities of infection (Cai and Schaffer, 1992; Hobbs and
DeLuca, 1999; Lomonte and Everett, 1999). These observations
suggest that HSV-1 at low MOI relies on ICP0 to trigger thedamage response cascade to facilitate its growth. Our finding
that cellular Chk2 deficiency impairs wild-type virus growth, but
does not further impair the growth of an ICP0-deficient mutant
virus (ICP0:lacZ; low-MOI infections), is consistent with this
proposal. Moreover, we found that ICP0:lacZ, despite its repli-
cation competence, failed to induce significant Chk2 phosphor-
ylation or G2/M arrest. These results confirmed that replication
competence alone is not sufficient to induce the damage res-
ponse pathway or pre-mitotic block. In addition, they strength-
ened the correlation between ICP0-dependent induction of these
responses and virus growth at low MOI.
While our results indicate that the role of Chk2 in virus
growth is tightly linked to ICP0, other components of the
damage response appear to maintain function in the absence of
ICP0. For example, it has been shown that cellular Mre11
deficiency, unlike Chk2 deficiency in our study, impairs the
growth of ICP0-deficient HSV-1 (Lilley et al., 2005), suggest-
ing that the contribution of Mre11 to virus growth is at least in
part ICP0-independent. Likewise, the same study reported ATM
activation following infection with replication-competent ICP0-
null virus at an MOI of 3 and we observed readily detectable
induction of γ-H2AX under similar conditions. Although ATM-
independent mechanisms of H2AX phosphorylation have been
described (Falck et al., 2005; Stiff et al., 2004), these results
suggest that ATM and Chk2 activations are uncoupled in ICP0-
null virus infection at elevated MOI; such uncoupling has also
been observed in IR-treated cells that were defective in Nbs1-
mediated recruitment of ATM to sites of DNA damage (Falck
et al., 2005). Together, the evidence suggests that ICP0-null
virus infection induces an incomplete damage response whose
deficiencies can be overcome by dosing effects.
In sum, we show that ICP0-induced G2/M arrest requires
ATM and Chk2 and correlates with activation of the ATM-
Chk2-Ccd25C DNA damage response pathway. It can be spe-
culated that cell-cycle blockade promotes virus growth by
diverting the cellular machinery required for normal cell-cyc-
ling processes to virus DNA replication. While it is well known
that ICP0 facilitates virus growth, it remains to be shown di-
rectly that this is a consequence of cell-cycle arrest mediated by
ICP0 induction of the ATM-Chk2-Ccd25C pathway.
Experimental procedures
Viruses and cells
Mutant viruses were derived from HSV-1 strain KOS. Re-
plication-defective recombinant TOZ22R was derived from the
previously described vector TOZ.1, which is deleted for the ICP4,
ICP27 and ICP22 genes and contains a lacZ expression cassette in
UL41 (Krisky et al., 1998), by insertion of a DsRed2 construct at
the ICP22 deletion site. QOZ22RHE.1 (referred to in this study as
QOZ22R) was derived from TOZ22R by replacement of an
ICP0 StuI–HpaI fragment (HSV-1 strain-17 genomic map posi-
tions 1554–5901) with a human cytomegalovirus IE promoter
(HCMVp)-enhanced green fluorescent protein (eGFP) expression
construct [1606-bp AseI–SspI fragment from a BglII–BamHI-
deleted derivative (unpublished results) of pEGFP-N1 (Clontech,
21H. Li et al. / Virology 375 (2008) 13–23Mountain View, CA)]. TOZ22R was grown on ICP4/ICP27-
complementing 7B cells (Krisky et al., 1998). QOZ22R was
grown on a new cell line designated 7B0-104 which was derived
from 7B cells by introduction of the ICP0 gene under control of
the ICP4 promoter (SacII–BamHI fragment, HSV-1 genomic
map positions 131590–131399). ICP0:lacZ (kindly provided by
S. Silverstein, Columbia University, NY) and HSV-1 KOS were
grown and titered on Vero cells.
HCT116 and HCT116(Chk2−/−) cells were a generous gift
from B. Vogelstein (Johns Hopkins University, MD) (Jallepalli
et al., 2003), HCT15, HCT15(Chk2+) and HCT15(Chk2-T68A)
cells were generously provided by J. Chen (Mayo Clinic,
Rochester, NY) (Wu and Chen, 2003), A-T lines GM05849,
GM02052 and GM09607 were from Coriell Cell Repositories
(Camden, NJ), AD-293 cells were purchased from Stratagene
(La Jolla, CA; catalog #240085), and Vero (CCL-81) and 293T
cells (CRL-11268) were from ATCC.
Southern blotting
Viral genomic DNA preparations were digested with DraI
overnight followed by BamHI digestion for 4 to 24 h. The
products were fractionated on a 1% TBE–agarose gel and blotted
to a Nytran Supercharge membrane (Schleicher & Schuell
BioScience, Keene, NH) by capillary transfer. The membrane
was cross-linked in anUVcross-linker (Stratagene) and incubated
overnight at 55 °C with a probe for the ICP0 locus (Fig. 1B). The
probe was prepared using a biotin random-prime labeling kit
according to the manufacturer's instructions (Pierce Chemical
Co., Rockford, IL). Following hybridization, the blot was pro-
cessed using the North2South chemiluminescent hybridization
and detection kit (Pierce Chemical Co.).
Virus infections and growth curves
Infections with TOZ22R and QOZ22R were performed in
60-mm dishes at an MOI of 2. The cells were collected at
various time points after infection for immunoblotting. Viral
growth kinetics were analyzed by infection of HCT116 and
HCT116(Chk2−/−) cells with HSV-1 KOS and ICP0:lacZ at
MOIs of 0.2. At various times post-infection, supernatants and
cleared cell lysates were collected, combined, and titered on
Vero (HSV-1 KOS) or 7B0-104 cells (ICP0:lacZ).
Transfections
293T cells in 60-mm dishes were transfected with 0.5 µg
HCMV promoter-driven ICP0 expression plasmid E110 (kindly
provided by Dr. P. Lomonte, Université de Lyon, France) or
control plasmid pEGFP-C1 (Clontech) using LipofectAMINE-
Plus (Invitrogen, Carlsbad, CA). Cells were collected 24 h later
for immunoblotting, as described below.
ATM inhibition experiments
Cells were pretreated for 1 h with 0–30 µM KU-55933 (a
kind gift from Dr. G.C.M. Smith, KuDOS Pharmaceuticals,Cambridge, UK) (Hickson et al., 2004) and infected or
transfected in the continued presence of drug. Cells were
washed and incubated with fresh drug until harvest for plaque
assay (18 hpi) or immunoblotting (24 h post-transfection). Drug
toxicity was assessed by MTS assay using CellTiter96 reagents
according to the manufacturer's instructions (Promega, Madi-
son, WI).
Antibodies
Mouse anti-ICP0 antibody was obtained from Virusys (East
Coast Biologics, North Berwick, ME). General and phospho-
specific Chk1 (S317) and Chk2 (T68) antibodies were purchased
from Cell Signaling (Danvers, MA), ATM antibody from Epi-
tomics (Burlingame, CA), and phospho-S1981-specific ATM
antibody from Rockland Immunochemicals (Gilbertsville, PA).
VP16, Cdc25A, Cdc25C, and phospho-S216-specific Cdc25C
antibodies were from Santa Cruz Biotechnology (Santa Cruz,
CA). Antibodies specific for γ-H2AX and phospho-S1423 Brca1
were from Cell Signaling, and β-actin antibodies from Chemicon
International (Temecula, CA). ICP0 and β-actin antibodies were
used at a dilution of 1:5000. All other primary antibodies were
used at a 1:1000 dilution. Peroxidase-conjugated secondary anti-
bodies were obtained from Santa Cruz Biotechnology and used at
a dilution of 1:2000.
Immunoblotting
Infected or transfected cells were washedwith cold phosphate-
buffered saline (PBS; 0.15 M NaCl, 0.01 M Na2HPO4, 0.01 M
NaH2PO4, pH 7.4) and lysed by adding 500 µl lysis buffer
containing 6 M urea, 2% SDS, 10% glycerol, 62.5 mMTris–HCl
(pH 6.8), 5% β-mercaptoethanol, and 5 mg/ml bromophenol
blue. The lysates were sonicated for 15 s using an ultrasonic
processor (Heat Systems-Ultrasonics, Farmingdale, NY) and the
supernatants were adjusted for equivalent protein concentrations,
boiled, and subjected to 10% SDS-PAGE. The proteins were
transferred to an Immobilon-P (Millipore Corp, Bedford, MA)
membrane using a Bio-Rad Mini Trans-Blot Cell (Bio-Rad
Laboratories, Hercules, CA). The membrane was blocked with
Tris-buffered saline (TBS-T) containing 5% non-fat dry milk and
0.05% Tween-20 for 1 h and reacted overnight at 4 °C with
primary antibody. Themembranewas then rinsed three timeswith
TBS-T containing 0.5% Tween-20 and reacted with secondary
antibody. Immunoblots were developed by enhanced chemilu-
minescence detection according to the manufacturer's instruc-
tions (ECL, Amersham Pharmacia Biotech, Piscataway, NJ).
Cell-cycle analysis
Cells were seeded in 60-mm dishes and infected at MOIs of 2
(TOZ22R and QOZ22R) or 5 (ICP0:lacZ). Cells were harvested
at the indicated time points, washed once with cold PBS, fixed
with cold 95% ethanol, and incubated with 50 mg/ml RNase A
for 30 min. Cells were stained with 50 mg/ml propidium iodide
solution for 10 min and cell-cycle distribution was determined
by flow cytometry (Cell Quest, Becton Dickinson, Mountain
22 H. Li et al. / Virology 375 (2008) 13–23View, CA). DNA content and cell-cycle stage were established
using WinCycle software (Phoenix Flow Systems, San Diego,
CA). At least 25,000 cells were counted per experiment. The
data are presented as histograms in which cell numbers are
plotted against DNA content.
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